Camila Rosat Consiglio
YOU?
Author Swipe
View article: The essential integration of sex and gender in immunological research
The essential integration of sex and gender in immunological research Open
View article: Exogenous estrogen enhances T cell activation in male primates
Exogenous estrogen enhances T cell activation in male primates Open
View article: Decoding sex differences in human immunity through systems immunology
Decoding sex differences in human immunity through systems immunology Open
Immune function varies widely across humans. Biological sex is a key factor underlying human immune variability, with men presenting with more severe infections and increased cancer rates, while women exhibit higher vaccine responses and p…
View article: 7820 Immune system adaptation during gender-affirming testosterone treatment
7820 Immune system adaptation during gender-affirming testosterone treatment Open
Disclosure: T. Lakshmikanth: None. C. Consiglio: None. F. Sardh: None. R. Forlin: None. J. Wang: None. Z. Tan: None. H. Barencilla: None. L. Rodriguez: None. J. Sugrue: None. P. Noori: None. M. Ivanchenko: None. L. Piñero Páez: None. L. Go…
View article: 7820 Immune system adaptation during gender-affirming testosterone treatment
7820 Immune system adaptation during gender-affirming testosterone treatment Open
Disclosure: T. Lakshmikanth: None. C. Consiglio: None. F. Sardh: None. R. Forlin: None. J. Wang: None. Z. Tan: None. H. Barencilla: None. L. Rodriguez: None. J. Sugrue: None. P. Noori: None. M. Ivanchenko: None. L. Piñero Páez: None. L. Go…
View article: Author Correction: Immune system adaptation during gender-affirming testosterone treatment
Author Correction: Immune system adaptation during gender-affirming testosterone treatment Open
View article: Immune system adaptation during gender-affirming testosterone treatment
Immune system adaptation during gender-affirming testosterone treatment Open
View article: Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications
Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications Open
Although sex and gender are recognized as major determinants of health and immunity, their role is rarely considered in clinical practice and public health. We identified six bottlenecks preventing the inclusion of sex and gender considera…
View article: Supplementary Figures from Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression
Supplementary Figures from Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression Open
Supplementary figures 1-6
View article: Data from Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression
Data from Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression Open
Androgen receptor (AR) antagonism increases overall survival in prostate cancer; however, treatment failure leads to tumor progression and patient mortality. The effect of AR modulation on AR+ nontumor cells that participate in …
View article: Data from Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression
Data from Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression Open
Androgen receptor (AR) antagonism increases overall survival in prostate cancer; however, treatment failure leads to tumor progression and patient mortality. The effect of AR modulation on AR+ nontumor cells that participate in …
View article: Supplementary Figures from Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression
Supplementary Figures from Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression Open
Supplementary figures 1-6
View article: Androgen Receptor Signaling Positively Regulates Monocytic Development
Androgen Receptor Signaling Positively Regulates Monocytic Development Open
Myeloid cells are critical cells involved in the orchestration of innate and adaptive immune responses. Most myeloid cells derive from the adult bone marrow in a process called myelopoiesis, a tightly controlled process that ensures consta…
View article: The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 Open
View article: The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Consiglio et al.
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Consiglio et al. Open
Datasets are included in folders according to the figures in the manuscript "The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.". This project used multiple omics data from Plasma protein expression (Olink - NPX…
View article: Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19 Open
Severe disease of SARS-CoV-2 is characterized by vigorous inflammatory responses in the lung, often with a sudden onset after 5-7 days of stable disease. Efforts to modulate this hyperinflammation and the associated acute respiratory distr…
View article: Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression
Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression Open
Androgen receptor (AR) antagonism increases overall survival in prostate cancer; however, treatment failure leads to tumor progression and patient mortality. The effect of AR modulation on AR+ nontumor cells that participate in the resista…
View article: The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 Open
SUMMARY SARS-CoV-2 infection is typically very mild and often asymptomatic in children. A complication is the rare Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19, presenting 4-6 weeks after infection as high…
View article: Systems-level immunomonitoring from acute to recovery phase of severe COVID-19
Systems-level immunomonitoring from acute to recovery phase of severe COVID-19 Open
SUMMARY The immune response to SARS-CoV2 is under intense investigation, but not fully understood att this moment. Severe disease is characterized by vigorous inflammatory responses in the lung, often with a sudden onset after 5–7 days of …
View article: Stressful Beginnings with Long-Term Consequences
Stressful Beginnings with Long-Term Consequences Open
View article: Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection
Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection Open
Sex-based differences influence incidence and outcome of infectious disease. Women have a significantly greater incidence of urinary tract infection (UTI) than men, yet, conversely, male UTI is more persistent with greater associated morbi…
View article: p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli
p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli Open
Constitutive p16Ink4a expression, along with senescence-associated β-galactosidase (SAβG), are commonly accepted biomarkers of senescent cells (SCs). Recent reports attributed improvement of the healthspan of aged mice fo…